Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: New Haven CT, Norwich CT, Westbury NY, New York NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: New Haven CT, Boston MA, Rochester NY, Richmond VA,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase 2, Recruiting
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for
Familial Adenomatous Polyposis (FAP)
Location: New Haven CT, Boston MA, Danville PA, Baltimore MD,
Sponsor: Rapamycin Holdings Inc.
Sex: All
Age: 18+
Code: NCT06950385
Phase 3, Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: New Haven CT, Boston MA, Washington D.C. DC, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07029399
Phase 1, Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Location: New Haven CT, New York NY, Chapel Hill NC, Milwaukee WI,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18+
Code: NCT06656494
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, The Bronx NY, Baltimore MD, Columbus OH,
Sponsor: DynamiCure Biotechnology
Sex: All
Age: 18+
Code: NCT05785754
Phase 1, Recruiting
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06100705
Phase 2, Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: New Haven CT, New York NY, Rochester NY, Detroit MI,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase 2, Phase 3, Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, Madison WI, Houston TX, Seattle WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase 1, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Boston MA, Nashville TN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd
Sex: All
Age: 18+
Code: NCT03863145
Early Phase 1, Recruiting
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: New Haven CT, The Bronx NY, New York NY, Fairfax VA,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase 1, Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: New Haven CT, New York NY, Baltimore MD, Rockville MD,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06172478
Phase 2, Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: New Haven CT, New York NY, Providence RI, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase 1, Phase 2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase 1, Phase 2, Recruiting
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
for
Neoplasm, Cancer, Malignant Tumors
Location: New Haven CT, Boston MA, Fairfax VA, Grand Rapids MI,
Sponsor: Compugen Ltd
Sex: All
Age: 18+
Code: NCT06759649
Phase 1, Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)